Correlation Between Zentalis Pharmaceuticals and Mind Medicine
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Mind Medicine, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Mind Medicine.
Diversification Opportunities for Zentalis Pharmaceuticals and Mind Medicine
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Zentalis and Mind is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Mind Medicine go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Mind Medicine
Given the investment horizon of 90 days Zentalis Pharmaceuticals is expected to generate 1.59 times less return on investment than Mind Medicine. In addition to that, Zentalis Pharmaceuticals is 1.28 times more volatile than Mind Medicine. It trades about 0.04 of its total potential returns per unit of risk. Mind Medicine is currently generating about 0.08 per unit of volatility. If you would invest 684.00 in Mind Medicine on September 17, 2024 and sell it today you would earn a total of 32.00 from holding Mind Medicine or generate 4.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Mind Medicine
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Mind Medicine |
Zentalis Pharmaceuticals and Mind Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Mind Medicine
The main advantage of trading using opposite Zentalis Pharmaceuticals and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| Mind Medicine vs. Puma Biotechnology | Mind Medicine vs. Iovance Biotherapeutics | Mind Medicine vs. Zentalis Pharmaceuticals Llc | Mind Medicine vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |